An international workshop of toxicologic pathologists reviewed cystic keratinizing squamous lesions of the rat lung. These lesions develop in response to the chronic inhalation of diverse particulate materials. Controversy exists over the biological significance of these changes and their relevance to humans. For the first time, in one place, a group of pathologists analyzed slides from all available studies. The workshop reached a consensus as to classification of these unique pulmonary tissue responses and offers diagnostic criteria for application. Although additional research is needed, this working classification scheme should serve as a practical interim approach for pathologists and regulatory agencies.
INTRODUCTION
Cystic keratinizing lesions are often found in the rat lung after chronic exposure to high burdens of particulate material (3, 4, 9-11, 16, 25) . The nature and classification of these lesions has been the subject of much debate. These lesions have been termed squamous cysts (2) ; others have suggested the term &dquo;benign cystic squamous cell tumor&dquo; (12) , &dquo;proliferative keratin cyst,&dquo; (3) or squamous cell carcinomas (1) . In addition to different terminology, the biological nature of these lesions has also been subject to debate (4, 11) . Some consider that most represent a form of neoplasia (4, 8) , whereas other favor a nonneoplastic nature for these lesions (3) . In general, most investigators have had the opportunity to investigate the lesions in only 1 or 2 long-term studies. This is quite limiting because even with prolonged exposure the incidence of lesions is often quite low.
To provide an opportunity for a broader review of the morphology and behavior of the lesions, the Deutsche Forschungsgemeinschaft organized a workshop, where investigators had the opportunity to review cystic keratinizing lesions from 13 studies including 11 different compounds. The inhalation exposures ranged from compounds considered to be relatively inert (talc, titanium dioxide) to chemicals that were considered to be moderately toxic (quartz, nickel oxide) to compounds that may have greater potential for toxicity (diesel exhaust, tar/pitch aerosol). More than 60 cystic keratinizing lesions were available to 11 pulmonary pathologists who had the opportunity to review and discuss the lesions. This was a unique opportunity because few of the inves-tigators present had been able previously to review such a wide spectrum of lesions from such a diversity of inhalation studies.
The meeting provided an opportunity for all lesions to be reviewed and discussed using a microscope that provides oculars for all participants. This allowed detailed discussion of the salient features that provided morphological evidence in support of the terminology and proposed biological behavior of the lesions. This article reports the consensus opinion for the classification of cystic keratinizing lesions that occur in the rat lung following long-term exposure to particulates.
MATERIALS AND METHODS
The participants met and discussed the general meeting objectives. They then individually reviewed 61 histological slides from 13 studies. These slides were from 5 sources and included 11 different test substances (Table  I) The 61 slides, which were from 56 rats (and included approximately 100 keratinizing lesions), were studied during the workshop over a period of 2 days. During the initial review, each pathologist reviewed all of the lesions and submitted diagnoses. The diagnoses were tabulated.
The lesions were then discussed in a general format. A draft classification scheme with classification criteria was proposed. Selected lesions that were considered to be classic examples for each diagnostic category were then reviewed. The draft classification scheme and diagnostic criteria were then revised, and selected lesions were again reviewed using a multiheaded microscope that accommodated all participants. Once there was general agreement on the main categories and classification criteria, lesions that often fell between the categories were reviewed and discussed. There was a general attempt to reach consensus on as many points as possible. Where areas of disagreement remained, this was noted and the review moved on to other cases. Although the main document was drafted during the meeting, this article reflects discussions and modifications that took place with further reflections and literature review. Participants invited but unable to attend were sent draft copies of this manuscript. All participants have had the opportunity to provide written comments and suggestions and these have been incorporated into this article. We feel that this manuscript represents a reasonable consensus of all participants and reflects our current state of knowledge. Table I lists the studies available for review by the workshop participants.
RESULTS
There was almost immediate agreement that the spectrum of cystic keratinizing lesions represented a family of lesions that contained many morphological similarities. It was apparent that diverse compounds resulted in lesions that were morphologically similar. It was also apparent that these lesions generally occurred with low frequency, although some studies produced frequencies as high as 20%. These cystic keratinizing lesions tended to occur late in the study, rarely before 20 mo exposure, and they generally only occurred in the highest exposure concentrations. Cystic keratinizing lesions were rarely found in lower concentrations or controls. The lesions were also very uncommon in male rats.
When a large number of lesions was reviewed over a short period of time, it became apparent that they comprised a family of related morphological changes that varied from squamous metaplasia to invasive squamous cell carcinoma. The hallmark of the lesions was the propensity to form large cysts containing keratin. In fact, the lesions are often noted grossly as large pulmonary nodules. Histologically, much of the nodule seen grossly is shown to be comprised of a large keratin-filled cyst. The spectrum of lesions, diagnostic criteria, and suggested terminology follow.
Pulmonary Squamous Cell Metaplasia
Pulmonary squamous cell metaplasia arises as an area of squamous metaplasia, often with an associated inflammatory infiltrate (Fig. 1 ). Even in early lesions, there is X210. a tendency for the accumulation of excessive keratin. Many of the lesions examined from the series of studies appeared to arise in the alveolar region (Fig. 2 ). The diagnostic criteria included a transition of alveolar cells in a gradual manner into squamous metaplastic cells and distortion but not obliteration of alveolar structure. There often is the presence of an associated inflammatory reaction with increased stromal collagen. If the lesion formed a discrete cyst, then the appropriate diagnosis was considered to be keratinizing cyst.
Pulmonary Keratinizing Cyst
Pulmonary keratinizing cysts often were quite large; showing abundant keratin (K) and a thin wall lined by squamous epithelium (arrow). H&E.
X54.
flattened squamous epithelium ( Fig. 5 ) that usually showed orderly maturation. The lesions often occupied a large area of pulmonary parenchyma, but compression of the adjacent lung was usually inconspicuous. The narrow rim of epithelium was often striking compared to the large central area of keratin. The diagnostic criteria included the presence of a thin uniform cyst wall that was composed of well-differentiated squamous cells with an orderly process of squamous epithelial maturation. Mitotic figures are rare or absent. The cystic cavity is filled with keratin and reduces pulmonary parenchyma. Occasionally these lesions were quite large. The size of the lesion is not an important criteria but the thickness and nature of the cyst wall is important.
The Society of Toxicologic Pathology in its 1991 AFIP publication (19) cysts,&dquo; which appears analogous to the pulmonary keratinizing cyst we describe. Of interest, in the same AFIP publication, the authors did not recognize any benign cystic keratinizing tumors in their classification. This may be a result of the more limited number of lesions available for review. The members of the workshop had the opportunity to review the entire spectrum of pathology caused by diverse agents. This perspective allows for a more comprehensive classification.
Pulmonary Cystic Keratinizing Epithelioma
Pulmonary cystic keratinizing epithelioma lesions had a more complex, thicker cyst wall than keratinizing cysts (Figs. 6 and 7). A prominent feature was that these lesions appeared to grow by filling contiguous alveoli giving a roughed or cobblestone appearance to the outer portion of the lesions (Fig. 8 ). This is in contrast to pulmonary keratinizing cysts, where both the surface lining the cyst and the rim adjacent to the pulmonary parenchyma had a smooth, sharply demarcated appearance. Cystic keratinizing epithelioma was also characterized by a lack of orderly maturation and increased mitotic figures (Figs. [9] [10] [11] . Occasionally, the lesion contained a focal malignant area. If any such malignant area is found, then the proper diagnosis is squamous cell carcinoma. In general, there was little disagreement FIG. 9. -Cystic keratinizing epithelioma. In addition to squamous cells, areas of more basal cells may be found in the wall of a cystic keratinizing epithelioma (arrows). H&E.
x 210. clude a cyst wall that is usually thicker than that of a . keratin cyst and can be irregular in appearance due to local variations in proliferative activity. The cyst wall often exhibits peripheral outgrowth of cells. There is often a focal or diffuse increase in the number of mitoses per microscopic field and cell pleomorphism may be found. An important criterion is disorganization of basal cells in foci of active cellular proliferation. This feature was important in determining that the lesions should be considered a benign neoplasm and not just hyperplasia. There was often a sharp demarcation between peripheral, proliferating epithelioma cells and ad- jacent epithelial or connective tissue structures. There was abrupt interfacing between epithelioma cells and epithelium of adjacent bronchioli sometimes with epithelioma cells infiltrating between bronchioli epithelium and its basement membrane (Fig. 12 ). This feature was useful in indicating the neoplastic (epitheliomatous) nature of the lesion. Most lesions have characteristically a central, keratin-filled cavity. Rarely, an epithelioma was found that did not contain a central keratin-filled area and showed little or no keratinization (Figs. 13 and 14 ).
Pulmonary Squamous Cell Carcinoma
Generally, squamous cell carcinomas were uncommon in the studies, but in the cases where they occurred there was little disagreement among participants. The squamous cell carcinomas appeared to arise in 2 different patterns and may have a different pathogenesis. Some squa- mous cell carcinomas arose from cystic keratinizing lesions. These carcinomas were considered to have a keratinizing pattern. In most cases, the predominant lesion was a large squamous cystic lesion with focal or diffuse malignancy in the wall (Figs. 15 and 16 ). Even when the squamous cell carcinomas invaded the lung, there was abundant keratin production and the cells produced keratin pearls (Fig. 17 ). In other carcinomas, little or no keratin production was seen. These lesions were classified as nonkeratinizing pattern. The cells were clearly squamous cells, but there was little or no keratin production ( Figs. 18 and 19) . The keratinizing squamous cell carcinomas had evidence of invasive growth into adjacent tissue (Figs. 16 and increased mitotic activity. These lesions sometimes appeared to arise in the wall of cystic keratinizing epitheliomas but in other cases appeared to arise de novo. There was some variability in keratin production in these carcinomas. There was no evidence that the nonkeratinizing or poorly keratinizing squamous cell carcinomas arose from cystic keratinizing epitheliomas. These squamous cell carcinomas tended to be small lesions with plump and commonly basophilic cells occurring in solid nests separated by delicate septa, alveolar pattern. The nonkeratinizing or poorly keratinizing squamous cell carcinomas tended to be less pleomorphic and less invasive than the keratinizing type. Parakeratotic masses are often noted, and as the neoplasm becomes larger central necrosis is observed.
DISCUSSION
It is important to note that the purpose of the workshop was to characterize the morphologic aspects of these lesions and to propose a useful classification. Detailed protocols for each study and risk assessment reports were not reviewed because they were beyond the objectives of the workshop. This family of cystic keratinizing pulmonary lesions is of importance because they often occur with particulates that may be otherwise considered innocuous. It is hoped that the classification scheme and terminology will bring some consistency to the discussion of these lesions.
The keratinizing cystic lesions should be considered as a family of pathologic responses to a variety of inhaled particles (4) . These responses vary from focal squamous metaplasia to invasive squamous cell carcinoma. Whereas the histologic diagnosis of squamous cell metaplasia and squamous cell carcinoma generally offer little difficulty, this is often not true for separation between keratinizing cyst and cystic keratinizing epithelioma. It would appear both logical and practical to recognize that some of the lesions are benign tumors and designated keratinizing cystic epithelioma. As indicated in the diagnostic criteria of the classification scheme, these lesions have a complex, thickened cyst wall with a clear proliferative advantage, as observed by the peripheral encroachment on contiguous alveoli and other air spaces.
The more actively proliferating epitheliomas may progress to squamous cell carcinoma. However, it is not clear how often this occurs. From the studies reviewed, this evolution may depend on the material used and its concentration.
The workshop was unique in that it allowed a group of pulmonary and general pathologists with extensive ex- perience in toxicologic pathology to review slides from a comprehensive group of studies. The morphological similarities between the various lesions were striking. It is not known to what extent this morphological similarity translates into biological potential for lesions from different studies. For example, it is highly probable that lesions found after prolonged exposure to a genotoxic agent would have a different potential for malignant transformation than those that develop following exposure to a relatively inert compound. Although the workshop was able to agree on common terminology, classification, and diagnostic criteria for this family of keratinizing lesions, evaluation of each study must be done on a case-by-case basis. Thus, the innate toxicity of the test article, its concentration, and total biological profile must be considered.
To better understand the biology of this spectrum of uncommon keratinizing rat pulmonary lesions due to inhalation of particles, it is crucial that pathologists use similar terminology and classification criteria. It is hoped that the proposed diagnostic scheme will aid investigators as they continue to study these lesions. Further study may result in changes in classification; thus, this report should be considered as a working document for future investigation. Routine histopathology cannot resolve the critical questions: Which lesions may progress? Can benign lesions be distinguished from those with malignant potential and those that are not neoplastic?
It is unlikely that histological examination of cystic keratinizing lesions will resolve the issue of how often these lesions (and which lesions) proceed to malignancy. It is possible that the biological potential may vary with the compound question. For example, the keratinizing squamous cysts in the talc study do not appear to progress to squamous cell carcinoma (13) , but with nickel oxide (14) there may be more biological potential for progression. In humans, squamous cell carcinomas may arise from congenital keratin cysts (23), suggesting that in some cases cysts do have the potential to progress. The question is: Which lesions may progress, and how does one distinguish benign lesions from those with malignant potential?
Molecular markers in keratinizing squamous cysts may help in determining biological potential. In humans, p53 is an early marker of squamous cell carcinoma of the lung. The p53 mutations are usually missense changes with a relatively high proportion of G to T transversions. The p53 mutations are acquired at an early stage and persist throughout the progression to squamous cell carcinoma (26) . In one study, nuclear p53 protein was present in 0% of normal mucosas, 6.7% of squamous metaplasias, 29.5% of mild dysplasias, 26 .9% of moderate dysplasias, 59.7% of severe dysplasias, 58.5% of carcinomas in situ, 67.5% of microinvasive carcinomas, and 79.5% of invasive tumors (1) . Others suggest that hyperproliferation is an early event followed by DNA aneuploidy, followed by p53 immunoreactivity in the genesis of squamous cell carcinomas (6, 17) .
Inactivation of the p53 pathway may have a role in the development of rat lung neoplasms with a squamous cell carcinoma component, but the role appears to differ from that in human lung neoplasms. In studies of the lung neoplasms induced in rats by inhalation of diesel exhaust or carbon black (22), 7 of 13 squamous cell or adenosquamous carcinomas had immunoreactive levels of p53 protein, suggesting gene dysfunction. However, the reason for increased p53 protein could not be determined. Single-stranded conformational polymorphism analysis and direct sequencing of p53 did not detect any mutations in these neoplasms. In addition, the mdm2 gene product was not overexpressed, based on immunohistochemical analysis, indicating that increase in this gene product, a known mechanism for stabilization of p53 protein, was not operative. In a study of p53 alterations in plutoniuminduced lung neoplasms (7) , 2 out of 26 squamous cell carcinomas had immunoreactivity for p53 protein. Direct DNA sequence analysis of the tumors showed each tumor to have G to A transition mutations. One mutation was in the first position of codon 283 and the other in the second position of codon 280, both outside the mutational &dquo;hotspots&dquo; for p53. These results indicated that the role of the p53 in squamous tumors in rats is not the same as it is in human squamous tumors.
Markers other than p53 may also prove useful. Pulmonary carcinomas induced by N-nitrosobis(2-oxopropyl)amine (BOP) in WBN/Kob rats showed a significantly higher incidence of point mutations in the K-ras protooncogene in squamous cell carcinomas (71 %) than in adenocarcinomas (6%) (18) . In humans, cytokeratins CK8 and CK19 occur in a majority of squamous cell carcinomas whereas CK20 immunoreactivity is not found (21) . The overexpression of proteins encoded by the oncogenes c-fos, c-jun, c-myc, c-erbB-1, and c-erbB-2 protein levels in squamous cell lung carcinomas of patients correlates with shorter survival times (24) . In rats exposed to aerosols of 239Pu02, squamous cell carcinomas arose in areas of fibrosis and scarring (5) .
The molecular changes in rat lung adenocarcinomas are different from those seen in human lung adenocar-cinomas, further indicating that changes in molecular pathway dysfunctions in lung neoplasms should be extrapolated with care between the 2 species. For example, none of the 37 adenocarcinomas induced by inhaled diesel exhaust or carbon black were immunoreactive with p53 antibody (22) , and only 3 of 50 had K-ras gene mutations. In a study of beryllium lung tumors in rats (15) , none of 24 adenocarcinomas were immunoreactive for p53 protein, only 2 of 12 had K-ras mutations, and none of 12 had rearrangements of the c-raf-1 protooncogene.
In addition to the question of progression in the rodent (rat) model, a second question is the relevance of these lesions for humans in determining potential hazard of particulate inhalation. This is a difficult issue to resolve and a morphological review of the keratinizing cystic lesion in rats after inhalation of instillation of particulate materials does not provide much information on species extrapolation. These lesions are also uncommon (1, 22) even in rats exposed to radioactive particles (7) . These lesions have not been reported in the literature in mice or hamsters exposed to dust under similar conditions. The Pulmonary Pathology Registry, Armed Forces Institute of Pathology, Washington, D.C., was unable to identify comparable lesions in humans. Thus, it would appear that keratinizing cystic pulmonary lesions occur predominantly in the rat with a possible trend to gender specificity (occurring in a higher incidence in female rats).
On the other hand, specific point mutations in K-ras occur in 39% of carcinomas with squamous differentiation and in 46% of adenocarcinomas of rats that inhaled plutonium (20) . In the same study, 60% of the adenomas, 27% of the alveolar epithelial hyperplasias, and 27% of the squamous metaplasias have K-ras point mutations, indicating that K-ras activation is an early molecular lesion in the progression of plutonium-induced tumors. In rats exposed to aerosols of PuO, squamous cell carcinomas arose in areas of fibrosis and scarring, suggesting that other pulmonary lesions may also be indicative of a carcinogenic process. Further elucidation of the biological nature of these lesions will require the use of newer techniques in molecular and cell biology. Markers for cell proliferation, assays for the expression of cytokines, analysis for molecular alterations, and loss of cell-to-cell communications are worthy of investigation. Fortunately, many of these techniques can be performed retrospectively on formalin-fixed tissues. The use of a standard terminology will facilitate comparison among pathological observations and among studies. As these newer methods are applied, the information generated will allow for further refinement of the classification scheme.
Until more specific and sensitive cytological methods are available, we believe that the proposed terminology and classification best reflect our current knowledge. Because this spectrum of lesions appears for the most part to be peculiar to the rat, they offer no opportunity for comparative human pathology studies. When these lesions occur in rats as part of a carcinogenicity study, they must be evaluated on a case-by-case basis and regarded as a part of the total biological profile of the test article. If the only evidence of tumorigenicity is the presence of cystic keratinizing epitheliomas, it may not have relevance to human safety evaluation of a substance or particle.
